
CME Group (CME) Stock Forecast & Price Target
CME Group (CME) Analyst Ratings
Bulls say
CME Group's stock outlook remains positive, primarily driven by robust growth in average daily volume (ADV) across key product segments, including a record performance in Henry Hub Natural Gas and significant increases in equity index and crypto futures. The firm's solid financial health is exemplified by a 9% year-over-year increase in its quarterly dividend, marking 14 consecutive years of dividend growth, alongside strong free cash flow generation that enables opportunistic share repurchases. Furthermore, the diversification into cash foreign exchange and collateral optimization, combined with the exclusive trading rights for S&P futures contracts, positions CME Group advantageously within the derivatives market.
Bears say
CME Group has recently faced challenges in its agricultural commodity sector, specifically with a noticeable decline in trading activity in soybean markets, attributed to favorable weather conditions in South America leading to potential record production. Additionally, a downside scenario projects approximately a 10% decrease in expected FY26 EPS, which could result in a significant negative impact on the stock's valuation, especially if open interest experiences a continuous decline, raising concerns about deteriorating market sentiment. Although market data and information services revenue slightly exceeded consensus expectations, overall trading volume remains soft, indicating potential ongoing pressures that could negatively affect the future performance of CME Group's stock.
This aggregate rating is based on analysts' research of CME Group and is not a guaranteed prediction by Public.com or investment advice.
CME Group (CME) Analyst Forecast & Price Prediction
Start investing in CME Group (CME)
Order type
Buy in
Order amount
Est. shares
0 shares